Advertisement
News
Advertisement

Foundation Announces a Comprehensive, Two-Day Educational Experience for Founders of Early-Stage Medical Device, Therapeutics, Diagnostics and Digital Health Companies

Fri, 02/24/2012 - 3:45am
The Associated Press

(http://www.kauffman.org)

Life science startups face more complex and daunting hurdles than new

enterprises in non-regulated industries do. To help aspiring and

early-stage life science entrepreneurs address these challenges, the

Ewing Marion Kauffman Foundation will hold a Kauffman Life Science

Ventures Summit June 22-23, 2012.

The Foundation announced a call for applications today for the

inaugural Summit, scheduled at the Mission Bay Conference Center at

the University of California-San Francisco.

"We surveyed early-stage and seasoned life science entrepreneurs to

find out what they considered critical needs for starting their

companies, and we built an agenda around their feedback," said

Dominique Pahud, director, advancing innovation at the Kauffman

Foundation. "We will answer the critical questions that founders must

address to start and grow viable life science companies. Every minute

of this event will focus on helping founders create a path to

successfully bring their innovations to market."

Industry experts and successful entrepreneurs will provide practical

guidance on commercializing innovations in each of four sectors:

medical device, therapeutics, diagnostics, and digital health.

Speakers and panelists representing each industry sector will share

lessons, advice and insights. Speakers include Steve Blank, serial

entrepreneur and author; Stephen Spielberg, deputy commissioner for

medical products and tobacco at the Food & Drug Administration; Paul

Yock, founder, Stanford Biodesign; Karl Handelsman, managing director,

CMEA Capital; Kim Popovits, CEO, Genomic Health; and more.

During the two-day Summit, participants will:

Up to 200 life science entrepreneurs across the four industry sectors

will be selected to attend. Applicants will be accepted based on two

factors: (1) how much they will benefit from the experience based on

where they are in their early-stage entrepreneurial journey, and (2)

the commercial viability of their plan.

The application and more information can be found at

www.kauffman.org/lifescienceapp(http://www.kauffman.org/lifescienceapp).

The deadline is April 2, 2012. Selected applicants will be advised by

April 13, and registration will open April 14. The registration fee is

$100 before May 4, 2012, and $125 after that date. More information is

available at.

The Kauffman Life Science Ventures Summit is sponsored by the

California Institute for Quantitative Biosciences (qb3), Stanford

BioDesign, Rock Health and MIT's H@cking Medicine.

About the Kauffman FoundationThe Ewing Marion Kauffman Foundation is a

private nonpartisan foundation that works to harness the power of

entrepreneurship and innovation to grow economies and improve human

welfare. Through its research and other initiatives, the Kauffman

Foundation aims to open young people's eyes to the possibility of

entrepreneurship, promote entrepreneurship education, raise awareness

of entrepreneurship-friendly policies, and find alternative pathways

for the commercialization of new knowledge and technologies. In

addition, the Foundation focuses on initiatives in the Kansas City

region to advance students' math and science skills, and improve the

educational achievement of urban students, including the Ewing Marion

Kauffman School, a college preparatory charter school for middle and

high school students set to open in 2011. Founded by late entrepreneur

and philanthropist Ewing Marion Kauffman, the Foundation is based in

Kansas City, Mo. and has approximately $2 billion in assets. For more

information, visit www.kauffman.org(http://www.kauffman.org/), and

follow the Foundation on

www.twitter.com/kauffmanfdn(http://www.twitter.com/kauffmanfdn) and

www.facebook.com/kauffmanfdn(http://www.facebook.com/kauffmanfdn).

Add to

Digg(http://digg.com/submit?phase2&urlhttp://www2.marketwire.com/mw/release_html_b1?release_id855459)Bookmark

with

del.icio.us(http://del.icio.us/post?v4&noui&jumpclose&urlhttp://www2.marketwire.com/mw/release_html_b1?release_id855459)Add

to

Newsvine(http://www.newsvine.com/_tools/seed&save?uhttp://www2.marketwire.com/mw/release_html_b1?release_id855459)

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading